Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Kabra Drugs Ltd.
Swot
Kabra Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Kabra Drugs Ltd. has 18 Strengths, 4 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(18)
Weakness
(4)
Opportunity
(0)
Threats
(0)
Others
(2)
MACD Crossover Above Signal Line
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
Stock with Low PE (PE < = 10)
MACD crossed above zero line previous end of day
MACD crossed above signal line previous end of day
Biggest Price Gainers from Open
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Profit to Loss Companies
Bullish or Bearish Candlestick Strength - Indices
Bullish Engulfing Pattern (Bullish Reversal)
